{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:21:50Z","timestamp":1791825710992,"version":"4.3.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["EMR\/2017\/000285"],"award-info":[{"award-number":["EMR\/2017\/000285"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-024-02391-9","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T19:04:04Z","timestamp":1717527844000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Focused cancer pathway analysis revealed unique therapeutic targets in retinoblastoma"],"prefix":"10.1007","volume":"41","author":[{"given":"Sekaran","family":"Balaji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anindita","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karuvel Kannan","family":"Saraswathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rathinavel","family":"Sethu Nagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhakrishnan","family":"Santhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerappan","family":"Muthukkaruppan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayyasamy","family":"Vanniarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,4]]},"reference":[{"issue":"9","key":"2391_CR1","doi-asserted-by":"publisher","first-page":"710","DOI":"10.2174\/1568009620666200504112711","volume":"20","author":"S Balaji","year":"2020","unstructured":"Balaji S, Santhi R, Kim U, Muthukkaruppan V, Priya CG, Vanniarajan A. Cancer stem cells with overexpression of neuronal markers enhance chemoresistance and invasion in retinoblastoma. Curr Cancer Drug Targets. 2020;20(9):710\u20139. https:\/\/doi.org\/10.2174\/1568009620666200504112711.","journal-title":"Curr Cancer Drug Targets"},{"issue":"9","key":"2391_CR2","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/jhg.2015.62","volume":"60","author":"K Thirumalairaj","year":"2015","unstructured":"Thirumalairaj K, Abraham A, Devarajan B, Gaikwad N, Kim U, Muthukkaruppan V, et al. A stepwise strategy for rapid and cost-effective RB1 screening in Indian retinoblastoma patients. J Hum Genet. 2015;60(9):547\u201352. https:\/\/doi.org\/10.1038\/jhg.2015.62.","journal-title":"J Hum Genet"},{"key":"2391_CR3","doi-asserted-by":"publisher","unstructured":"Mendonca V, Evangelista AC, B PM, MA MM, Faria P, Lucena E, et al. Molecular alterations in retinoblastoma beyond RB1. Exp Eye Res. 2021;211:108753.https:\/\/doi.org\/10.1016\/j.exer.2021.108753","DOI":"10.1016\/j.exer.2021.108753"},{"issue":"1","key":"2391_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/ceo.12132","volume":"42","author":"BL Theriault","year":"2014","unstructured":"Theriault BL, Dimaras H, Gallie BL, Corson TW. The genomic landscape of retinoblastoma: a review. Clin Exp Ophthalmol. 2014;42(1):33\u201352. https:\/\/doi.org\/10.1111\/ceo.12132.","journal-title":"Clin Exp Ophthalmol"},{"issue":"7","key":"2391_CR5","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ebiom.2015.06.022","volume":"2","author":"IE Kooi","year":"2015","unstructured":"Kooi IE, Mol BM, Moll AC, van der Valk P, de Jong MC, de Graaf P, et al. Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progression. EBioMedicine. 2015;2(7):660\u201370. https:\/\/doi.org\/10.1016\/j.ebiom.2015.06.022.","journal-title":"EBioMedicine"},{"issue":"3","key":"2391_CR6","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ygeno.2007.05.002","volume":"90","author":"S Chakraborty","year":"2007","unstructured":"Chakraborty S, Khare S, Dorairaj SK, Prabhakaran VC, Prakash DR, Kumar A. Identification of genes associated with tumorigenesis of retinoblastoma by microarray analysis. Genomics. 2007;90(3):344\u201353. https:\/\/doi.org\/10.1016\/j.ygeno.2007.05.002.","journal-title":"Genomics"},{"key":"2391_CR7","unstructured":"Ganguly A, Shields CL. Differential gene expression profile of retinoblastoma compared to normal retina. Mol Vis. 2010;16:1292\u2013303, https:\/\/pubmed.ncbi.nlm.nih.gov\/20664703"},{"issue":"2","key":"2391_CR8","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ccr.2011.07.005","volume":"20","author":"J McEvoy","year":"2011","unstructured":"McEvoy J, Flores-Otero J, Zhang J, Nemeth K, Brennan R, Bradley C, et al. Coexpression of normally incompatible developmental pathways in retinoblastoma genesis. Cancer Cell. 2011;20(2):260\u201375. https:\/\/doi.org\/10.1016\/j.ccr.2011.07.005.","journal-title":"Cancer Cell"},{"issue":"12","key":"2391_CR9","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.4103\/ijo.IJO_1611_18","volume":"67","author":"U Kim","year":"2019","unstructured":"Kim U, Rathi G, Chowdhary G, Srinavasan KG, Shanthi R, Krishna RSP. Accuracy of preoperative imaging in predicting optic nerve invasion in retinoblastoma: a retrospective study. Indian J Ophthalmol. 2019;67(12):2019\u201322. https:\/\/doi.org\/10.4103\/ijo.IJO_1611_18.","journal-title":"Indian J Ophthalmol"},{"key":"2391_CR10","doi-asserted-by":"publisher","unstructured":"Shields CL, Shields JA, Baez K, Cater JR, De Potter P. Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factors. Cancer. 1994;73(3):692\u20138.https:\/\/doi.org\/10.1002\/1097-0142(19940201)73:3<692::aid-cncr2820730331>3.0.co;2-8","DOI":"10.1002\/1097-0142(19940201)73:3<692::aid-cncr2820730331>3.0.co;2-8"},{"issue":"9","key":"2391_CR11","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1136\/bjo.77.9.544","volume":"77","author":"CL Shields","year":"1993","unstructured":"Shields CL, Shields JA, Baez KA, Cater J, Potter PVD. Choroidal invasion of retinoblastoma: metastatic potential and clinical risk factors. Br J Ophthalmol. 1993;77(9):544. https:\/\/doi.org\/10.1136\/bjo.77.9.544.","journal-title":"Br J Ophthalmol"},{"key":"2391_CR12","doi-asserted-by":"publisher","unstructured":"Bartha \u00c1, Gy\u0151rffy B. TNMplot.com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissues. Int J Mol Sci. 2021;22(5).https:\/\/doi.org\/10.3390\/ijms22052622","DOI":"10.3390\/ijms22052622"},{"key":"2391_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.144948;10.1016\/j.gene.2020.144948:144948.10.1016\/j.gene.2020.144948","author":"S Balaji","year":"2020","unstructured":"Balaji S, Vanniarajan A. Implication of pseudo reference genes in normalization of data from reverse transcription-quantitative pcR. Gene. 2020. https:\/\/doi.org\/10.1016\/j.gene.2020.144948;10.1016\/j.gene.2020.144948:144948.10.1016\/j.gene.2020.144948.","journal-title":"Gene"},{"issue":"7","key":"2391_CR14","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1093\/nar\/gkr1259","volume":"40","author":"H Laurell","year":"2012","unstructured":"Laurell H, Iacovoni JS, Abot A, Svec D, Maoret JJ, Arnal JF, et al. Correction of RT-qPCR data for genomic DNA-derived signals with ValidPrime. Nucleic Acids Res. 2012;40(7):e51. https:\/\/doi.org\/10.1093\/nar\/gkr1259.","journal-title":"Nucleic Acids Res"},{"key":"2391_CR15","doi-asserted-by":"publisher","unstructured":"Francis JH, Richards AL, Mandelker DL, Berger MF, Walsh MF, Dunkel IJ, et al. Molecular changes in retinoblastoma beyond rb1: findings from next-generation sequencing. Cancers (Basel). 2021;13(1).https:\/\/doi.org\/10.3390\/cancers13010149","DOI":"10.3390\/cancers13010149"},{"issue":"3","key":"2391_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4103\/0974-9233.65498","volume":"17","author":"M Kandalam","year":"2010","unstructured":"Kandalam M, Mitra M, Subramanian K, Biswas J. Molecular pathology of retinoblastoma. Middle East Afr J Ophthalmol. 2010;17(3):217\u201323. https:\/\/doi.org\/10.4103\/0974-9233.65498.","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"1","key":"2391_CR17","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s10020-022-00555-9","volume":"28","author":"Y Sun","year":"2022","unstructured":"Sun Y, Cheng Z, Liu S. MCM2 in human cancer: functions, mechanisms, and clinical significance. Mol Med. 2022;28(1):128. https:\/\/doi.org\/10.1186\/s10020-022-00555-9.","journal-title":"Mol Med"},{"issue":"12","key":"2391_CR18","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/s41419-021-04390-4","volume":"12","author":"J Yang","year":"2021","unstructured":"Yang J, Li Y, Han Y, Feng Y, Zhou M, Zong C, et al. Single-cell transcriptome profiling reveals intratumoural heterogeneity and malignant progression in retinoblastoma. Cell Death Dis. 2021;12(12):1100. https:\/\/doi.org\/10.1038\/s41419-021-04390-4.","journal-title":"Cell Death Dis"},{"issue":"5","key":"2391_CR19","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41419-022-04904-8","volume":"13","author":"C Wu","year":"2022","unstructured":"Wu C, Yang J, Xiao W, Jiang Z, Chen S, Guo D, et al. Single-cell characterization of malignant phenotypes and microenvironment alteration in retinoblastoma. Cell Death Dis. 2022;13(5):438. https:\/\/doi.org\/10.1038\/s41419-022-04904-8.","journal-title":"Cell Death Dis"},{"issue":"36","key":"2391_CR20","doi-asserted-by":"publisher","first-page":"e35038","DOI":"10.1097\/MD.0000000000035038","volume":"102","author":"F Xian","year":"2023","unstructured":"Xian F, Zhao C, Huang C, Bie J, Xu G. The potential role of CDC20 in tumorigenesis, cancer progression and therapy: a narrative review. Medicine (Baltimore). 2023;102(36):e35038. https:\/\/doi.org\/10.1097\/MD.0000000000035038.","journal-title":"Medicine (Baltimore)"},{"key":"2391_CR21","doi-asserted-by":"publisher","unstructured":"Zhang Y, Zhou L, Wang S, Wang M, Wu S. Exploration of retinoblastoma pathogenesis with bioinformatics. Transl Cancer Res. 2021;10(7):3527\u201337.https:\/\/doi.org\/10.21037\/tcr-21-1034","DOI":"10.21037\/tcr-21-1034"},{"key":"2391_CR22","doi-asserted-by":"publisher","unstructured":"Esposito F, Giuffrida R, Raciti G, Puglisi C, Forte S. Wee1 kinase: a potential target to overcome tumor resistance to therapy. Int J Mol Sci. 2021;22(19).https:\/\/doi.org\/10.3390\/ijms221910689","DOI":"10.3390\/ijms221910689"},{"key":"2391_CR23","doi-asserted-by":"publisher","unstructured":"Li A, Yang J, Zhang T, Li L, Li M. Long Noncoding RNA TRPM2-AS Promotes the Growth, Migration, and Invasion of Retinoblastoma via miR-497\/WEE1 Axis. Front Pharmacol. 2021;12.https:\/\/doi.org\/10.3389\/fphar.2021.592822","DOI":"10.3389\/fphar.2021.592822"},{"key":"2391_CR24","doi-asserted-by":"crossref","unstructured":"Kim N, Ko Y, Shin Y, Park J, Lee AJ, Kim KW, et al. Comprehensive analysis for anti-cancer target-indication prioritization of placental growth factor inhibitor (PGF) by use of omics and patient survival data. Biology. 2023;12(7):970, https:\/\/www.mdpi.com\/2079-7737\/12\/7\/970","DOI":"10.3390\/biology12070970"},{"issue":"1","key":"2391_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1136\/gutjnl-2020-322493","volume":"71","author":"S Aoki","year":"2022","unstructured":"Aoki S, Inoue K, Klein S, Halvorsen S, Chen J, Matsui A, et al. Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma. Gut. 2022;71(1):185\u201393. https:\/\/doi.org\/10.1136\/gutjnl-2020-322493.","journal-title":"Gut"},{"key":"2391_CR26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1755-8794-5-62","volume":"5","author":"J Liu","year":"2012","unstructured":"Liu J, Zhan X, Li M, Li G, Zhang P, Xiao Z, et al. Mitochondrial proteomics of nasopharyngeal carcinoma metastasis. BMC Med Genomics. 2012;5:62. https:\/\/doi.org\/10.1186\/1755-8794-5-62.","journal-title":"BMC Med Genomics"},{"issue":"2","key":"2391_CR27","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1128\/MCB.00868-14","volume":"35","author":"S Nath","year":"2015","unstructured":"Nath S, Chowdhury A, Dey S, Roychoudhury A, Ganguly A, Bhattacharyya D, et al. Deregulation of Rb-E2F1 axis causes chromosomal instability by engaging the transactivation function of Cdc20-anaphase-promoting complex\/cyclosome. Mol Cell Biol. 2015;35(2):356\u201369. https:\/\/doi.org\/10.1128\/MCB.00868-14.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"2391_CR28","doi-asserted-by":"publisher","first-page":"e970480","DOI":"10.4161\/23723548.2014.970480","volume":"2","author":"A Poppy Roworth","year":"2015","unstructured":"Poppy Roworth A, Ghari F, La Thangue NB. To live or let die - complexity within the E2F1 pathway. Mol Cell Oncol. 2015;2(1):e970480. https:\/\/doi.org\/10.4161\/23723548.2014.970480.","journal-title":"Mol Cell Oncol"},{"key":"2391_CR29","doi-asserted-by":"publisher","unstructured":"Hamidi M, Eriz A, Mitxelena J, Fernandez-Ares L, Aurrekoetxea I, Aspichueta P, et al. targeting e2f sensitizes prostate cancer cells to drug-induced replication stress by promoting unscheduled CDK1 activity. Cancers (Basel). 2022;14(19).https:\/\/doi.org\/10.3390\/cancers14194952","DOI":"10.3390\/cancers14194952"},{"issue":"12","key":"2391_CR30","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1038\/s41418-021-00823-x","volume":"28","author":"S Uxa","year":"2021","unstructured":"Uxa S, Castillo-Binder P, Kohler R, Stangner K, M\u00fcller GA, Engeland K. Ki-67 gene expression. Cell Death Differ. 2021;28(12):3357\u201370. https:\/\/doi.org\/10.1038\/s41418-021-00823-x.","journal-title":"Cell Death Differ"},{"issue":"9","key":"2391_CR31","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/ncb2309","volume":"13","author":"E Blanchet","year":"2011","unstructured":"Blanchet E, Annicotte JS, Lagarrigue S, Aguilar V, Clape C, Chavey C, et al. E2F transcription factor-1 regulates oxidative metabolism. Nat Cell Biol. 2011;13(9):1146\u201352. https:\/\/doi.org\/10.1038\/ncb2309.","journal-title":"Nat Cell Biol"},{"issue":"4","key":"2391_CR32","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ccr.2009.08.020","volume":"16","author":"HC Huang","year":"2009","unstructured":"Huang HC, Shi J, Orth JD, Mitchison TJ. Evidence that mitotic exit is a better cancer therapeutic target than spindle assembly. Cancer Cell. 2009;16(4):347\u201358. https:\/\/doi.org\/10.1016\/j.ccr.2009.08.020.","journal-title":"Cancer Cell"},{"key":"2391_CR33","doi-asserted-by":"publisher","unstructured":"Mrouj K, Andres-Sanchez N, Dubra G, Singh P, Sobecki M, Chahar D, et al. Ki-67 regulates global gene expression and promotes sequential stages of carcinogenesis. Proc Natl Acad Sci U S A. 2021;118(10).https:\/\/doi.org\/10.1073\/pnas.2026507118","DOI":"10.1073\/pnas.2026507118"},{"issue":"2","key":"2391_CR34","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10549-009-0571-2","volume":"122","author":"LM Murrow","year":"2010","unstructured":"Murrow LM, Garimella SV, Jones TL, Caplen NJ, Lipkowitz S. Identification of WEE1 as a potential molecular target in cancer cells by RNAi screening of the human tyrosine kinome. Breast Cancer Res Treat. 2010;122(2):347\u201357. https:\/\/doi.org\/10.1007\/s10549-009-0571-2.","journal-title":"Breast Cancer Res Treat"},{"key":"2391_CR35","doi-asserted-by":"publisher","first-page":"1298245","DOI":"10.3389\/fphar.2023.1298245","volume":"14","author":"T Jin","year":"2023","unstructured":"Jin T, Xu W, Chen R, Shen L, Gao J, Xu L, et al. Discovery of potential WEE1 inhibitors via hybrid virtual screening. Front Pharmacol. 2023;14:1298245. https:\/\/doi.org\/10.3389\/fphar.2023.1298245.","journal-title":"Front Pharmacol"},{"key":"2391_CR36","doi-asserted-by":"publisher","unstructured":"Yang C, Li Z, Li Q, Xia Y, Chan C-C, Yuan X, et al. Preclinical evaluation of SC0191, a small molecule inhibitor of Wee1 kinase. J Clin Oncol. 2020;38(15_suppl):e15637-e.https:\/\/doi.org\/10.1200\/JCO.2020.38.15_suppl.e15637","DOI":"10.1200\/JCO.2020.38.15_suppl.e15637"},{"key":"2391_CR37","doi-asserted-by":"publisher","unstructured":"Bruno S, Ghelli Luserna di Rora A, Napolitano R, Soverini S, Martinelli G, Simonetti G. CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies. J Exp Clin Cancer Res. 2022;41(1):159.https:\/\/doi.org\/10.1186\/s13046-022-02363-9","DOI":"10.1186\/s13046-022-02363-9"},{"key":"2391_CR38","doi-asserted-by":"publisher","unstructured":"Lub S, Maes A, Maes K, De Veirman K, De Bruyne E, Menu E, et al. Inhibiting the anaphase promoting complex\/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells. Oncotarget. 2016;7(4):4062\u201376.https:\/\/doi.org\/10.18632\/oncotarget.6768","DOI":"10.18632\/oncotarget.6768"},{"key":"2391_CR39","doi-asserted-by":"publisher","DOI":"10.3791\/62939;10.3791\/62939(175).10.3791\/62939","author":"ME Kim","year":"2021","unstructured":"Kim ME, Xu L, Prabakar RK, Shen L, Peng CC, Kuhn P, et al. Aqueous humor as a liquid biopsy for retinoblastoma: clear corneal paracentesis and genomic analysis. J Vis Exp. 2021. https:\/\/doi.org\/10.3791\/62939;10.3791\/62939(175).10.3791\/62939.","journal-title":"J Vis Exp"},{"issue":"8","key":"2391_CR40","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1136\/bjo.2010.193961","volume":"95","author":"J Levy","year":"2011","unstructured":"Levy J, Frenkel S, Baras M, Neufeld M, Pe\u2019er J. Calcification in retinoblastoma: histopathologic findings and statistical analysis of 302 cases. Br J Ophthalmol. 2011;95(8):1145\u201350. https:\/\/doi.org\/10.1136\/bjo.2010.193961.","journal-title":"Br J Ophthalmol"},{"key":"2391_CR41","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.pharmthera.2015.04.002","volume":"151","author":"L Wang","year":"2015","unstructured":"Wang L, Zhang J, Wan L, Zhou X, Wang Z, Wei W. Targeting Cdc20 as a novel cancer therapeutic strategy. Pharmacol Ther. 2015;151:141\u201351. https:\/\/doi.org\/10.1016\/j.pharmthera.2015.04.002.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"2391_CR42","doi-asserted-by":"publisher","first-page":"13302","DOI":"10.1038\/s41598-017-13440-x","volume":"7","author":"CHY Cheung","year":"2017","unstructured":"Cheung CHY, Hsu CL, Chen KP, Chong ST, Wu CH, Huang HC, et al. MCM2-regulated functional networks in lung cancer by multi-dimensional proteomic approach. Sci Rep. 2017;7(1):13302. https:\/\/doi.org\/10.1038\/s41598-017-13440-x.","journal-title":"Sci Rep"},{"issue":"2","key":"2391_CR43","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00412-018-0659-8","volume":"127","author":"X Sun","year":"2018","unstructured":"Sun X, Kaufman PD. Ki-67: more than a proliferation marker. Chromosoma. 2018;127(2):175\u201386. https:\/\/doi.org\/10.1007\/s00412-018-0659-8.","journal-title":"Chromosoma"},{"issue":"19","key":"2391_CR44","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.4161\/cc.26062","volume":"12","author":"K Do","year":"2013","unstructured":"Do K, Doroshow JH, Kummar S. Wee1 kinase as a target for cancer therapy. Cell Cycle. 2013;12(19):3159\u201364. https:\/\/doi.org\/10.4161\/cc.26062.","journal-title":"Cell Cycle"},{"key":"2391_CR45","doi-asserted-by":"publisher","unstructured":"Tang A, Gao K, Chu L, Zhang R, Yang J, Zheng J. Aurora kinases: novel therapy targets in cancers. Oncotarget. 2017;8(14):23937\u201354.https:\/\/doi.org\/10.18632\/oncotarget.14893","DOI":"10.18632\/oncotarget.14893"},{"key":"2391_CR46","doi-asserted-by":"publisher","unstructured":"Hsu J, Sage J. Novel functions for the transcription factor E2F4 in development and disease. Cell Cycle. 2016;15(23):3183\u201390.https:\/\/doi.org\/10.1080\/15384101.2016.1234551","DOI":"10.1080\/15384101.2016.1234551"},{"issue":"10","key":"2391_CR47","doi-asserted-by":"publisher","first-page":"7797","DOI":"10.1007\/s13277-015-3520-1","volume":"36","author":"S Wang","year":"2015","unstructured":"Wang S, Akhtar J, Wang Z. Anti-STMN1 therapy improves sensitivity to antimicrotubule drugs in esophageal squamous cell carcinoma. Tumour Biol. 2015;36(10):7797\u2013806. https:\/\/doi.org\/10.1007\/s13277-015-3520-1.","journal-title":"Tumour Biol"},{"issue":"1","key":"2391_CR48","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3858\/emm.2012.44.1.023","volume":"44","author":"KJ Kim","year":"2012","unstructured":"Kim KJ, Cho CS, Kim WU. Role of placenta growth factor in cancer and inflammation. Exp Mol Med. 2012;44(1):10\u20139. https:\/\/doi.org\/10.3858\/emm.2012.44.1.023.","journal-title":"Exp Mol Med"},{"issue":"1\u20133","key":"2391_CR49","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ejphar.2009.01.045","volume":"610","author":"K Tamura","year":"2009","unstructured":"Tamura K, Hashimoto K, Suzuki K, Yoshie M, Kutsukake M, Sakurai T. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells. Eur J Pharmacol. 2009;610(1\u20133):61\u20137. https:\/\/doi.org\/10.1016\/j.ejphar.2009.01.045.","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"2391_CR50","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1158\/0008-5472.CAN-15-1796","volume":"76","author":"Y Takayama","year":"2016","unstructured":"Takayama Y, Hattori N, Hamada H, Masuda T, Omori K, Akita S, et al. Inhibition of PAI-1 limits tumor angiogenesis regardless of angiogenic stimuli in malignant pleural mesothelioma. Cancer Res. 2016;76(11):3285\u201394. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-1796.","journal-title":"Cancer Res"},{"issue":"2","key":"2391_CR51","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11912-009-0017-3","volume":"11","author":"B Hu","year":"2009","unstructured":"Hu B, Cheng SY. Angiopoietin-2: development of inhibitors for cancer therapy. Curr Oncol Rep. 2009;11(2):111\u20136. https:\/\/doi.org\/10.1007\/s11912-009-0017-3.","journal-title":"Curr Oncol Rep"},{"issue":"2","key":"2391_CR52","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/cgt.2016.79","volume":"24","author":"M Sharifi","year":"2017","unstructured":"Sharifi M, Moridnia A. Apoptosis-inducing and antiproliferative effect by inhibition of miR-182-5p through the regulation of CASP9 expression in human breast cancer. Cancer Gene Ther. 2017;24(2):75\u201382. https:\/\/doi.org\/10.1038\/cgt.2016.79.","journal-title":"Cancer Gene Ther"},{"key":"2391_CR53","doi-asserted-by":"publisher","unstructured":"Lu J, Tan M, Cai Q. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism. Cancer letters. 2015;356(2 Pt A):156\u201364.https:\/\/doi.org\/10.1016\/j.canlet.2014.04.001","DOI":"10.1016\/j.canlet.2014.04.001"},{"issue":"1","key":"2391_CR54","doi-asserted-by":"publisher","first-page":"6380","DOI":"10.1038\/s41598-020-63448-z","volume":"10","author":"M Frederick","year":"2020","unstructured":"Frederick M, Skinner HD, Kazi SA, Sikora AG, Sandulache VC. High expression of oxidative phosphorylation genes predicts improved survival in squamous cell carcinomas of the head and neck and lung. Sci Rep. 2020;10(1):6380. https:\/\/doi.org\/10.1038\/s41598-020-63448-z.","journal-title":"Sci Rep"},{"key":"2391_CR55","doi-asserted-by":"publisher","unstructured":"Aoude LG, Pritchard AL, Robles-Espinoza CD, Wadt K, Harland M, Choi J, et al. Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma. J Natl Cancer Inst. 2015;107(2).https:\/\/doi.org\/10.1093\/jnci\/dju408","DOI":"10.1093\/jnci\/dju408"},{"issue":"2","key":"2391_CR56","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/(sici)1098-2264(199806)22:2<152::aid-gcc10>3.0.co;2-s","volume":"22","author":"T Kohno","year":"1998","unstructured":"Kohno T, Takahashi M, Manda R, Yokota J. Inactivation of the PTEN\/MMAC1\/TEP1 gene in human lung cancers. Genes Chromosom Cancer. 1998;22(2):152\u20136. https:\/\/doi.org\/10.1002\/(sici)1098-2264(199806)22:2%3c152::aid-gcc10%3e3.0.co;2-s.","journal-title":"Genes Chromosom Cancer"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-024-02391-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-024-02391-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-024-02391-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T02:33:54Z","timestamp":1719887634000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-024-02391-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,4]]},"references-count":56,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["2391"],"URL":"https:\/\/doi.org\/10.1007\/s12032-024-02391-9","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,4]]},"assertion":[{"value":"12 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declared that none of the authors has financial and personal competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Institutional Review Board of Aravind Medical Research Foundation (IRB2017009BAS).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All tumor samples were collected with the informed consent from patient\/family.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"168"}}